1301. Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy

BACKGROUND: Voriconazole (Vori) is often used for prophylactic anti-fungal therapy in induction chemotherapy for Acute Myeloid Leukemia (AML) patients due to predictable absorption and an extended spectrum antifungal activity. Vori is metabolized predominately by CYP2C19 to metabolites with less ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Singam, Hareesh v, Pasikhova, Yanina, Quilitz, Rod, Greene, John N, Baluch, Aliyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777358/
http://dx.doi.org/10.1093/ofid/ofaa439.1484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777358/
http://dx.doi.org/10.1093/ofid/ofaa439.1484

Ejemplares similares